Latest Manufacturing News

Big River Industries reported a significant $17 million loss for the half-year ending December 2024, driven by a $20 million non-cash impairment charge and a 3.3% revenue decline. The company also announced a reduced fully franked interim dividend of 2 cents per share.

Heartland Group Holdings reports a sharp rise in impairment expenses to $49.6 million for its New Zealand banking arm, driven by worsening economic conditions. Despite this, the bank remains well capitalised and expects to maintain dividend payments.

Reliance Worldwide Corporation Limited has announced an ordinary dividend of USD 0.025 per share for the six months ending December 31, 2024, payable in April 2025. The dividend is unfranked and will be paid in Australian dollars based on a recent exchange rate.

GWR is actively pursuing transformative project acquisitions across global jurisdictions while trading significantly below its cash and investment backing. The company’s robust cash position and critical minerals investments position it well amid shifting global supply dynamics.

Althea Group Holdings has raised $4 million through a share and loan note placement to boost its THC beverage production and infrastructure across North America, targeting rapid growth in the U.S. and Canada.

HyTerra Limited faces operational delays at its Nemaha Project due to severe winter weather but strengthens its management team with a key executive hire to drive 2025 exploration forward.

Green Critical Minerals has announced a major breakthrough with its VHD Graphite technology, delivering thermal diffusivity far surpassing copper and aluminium, promising a revolution in AI and high-performance electronics cooling.

Lithium Universe Limited’s Definitive Feasibility Study confirms the economic viability of its Bécancour Lithium Refinery, projecting robust returns even amid subdued lithium prices. The project aims to produce 18,270 tonnes per year of battery-grade lithium carbonate, leveraging proven Jiangsu technology and a counter-cyclical development strategy.

Recce Pharmaceuticals reports strong Phase II results for its RECCE® 327 topical gel, achieving a 93% efficacy rate in treating serious skin infections and setting the stage for accelerated Phase 3 trials.

Toys"R"Us ANZ has entered a strategic three-year partnership with Directed Electronics Australia to co-develop private label products and enhance marketing capabilities, marking a pivotal step in its growth strategy.

IperionX has landed a $47.1 million contract from the U.S. Department of Defense to develop a domestic titanium supply chain, marking a significant step toward reducing reliance on foreign sources for this critical metal.

Sprintex has completed commissioning of its compressor systems with Mest Water and is poised to receive a €3.8 million purchase order, marking a pivotal step in expanding its environmental technology footprint across the EU.